Paratek Pharmaceuticals, Inc. - FORM 10-K - EX-16.2 - April 2, 2015

Attached files

file filename
10-K - 10-K - Paratek Pharmaceuticals, Inc.d853473d10k.htm
EX-31.1 - EX-31.1 - Paratek Pharmaceuticals, Inc.d853473dex311.htm
EX-32.1 - EX-32.1 - Paratek Pharmaceuticals, Inc.d853473dex321.htm
EX-21.1 - EX-21.1 - Paratek Pharmaceuticals, Inc.d853473dex211.htm
EX-23.1 - EX-23.1 - Paratek Pharmaceuticals, Inc.d853473dex231.htm
EX-16.3 - EX-16.3 - Paratek Pharmaceuticals, Inc.d853473dex163.htm
EX-31.2 - EX-31.2 - Paratek Pharmaceuticals, Inc.d853473dex312.htm
EX-10.7 - EX-10.7 - Paratek Pharmaceuticals, Inc.d853473dex107.htm
EX-32.2 - EX-32.1 - Paratek Pharmaceuticals, Inc.d853473dex322.htm
EX-10.20 - EX-10.20 - Paratek Pharmaceuticals, Inc.d853473dex1020.htm
EX-10.22 - EX-10.22 - Paratek Pharmaceuticals, Inc.d853473dex1022.htm
EX-10.19 - EX-10.19 - Paratek Pharmaceuticals, Inc.d853473dex1019.htm
EX-10.21 - EX-10.21 - Paratek Pharmaceuticals, Inc.d853473dex1021.htm
EX-10.16 - EX-10.16 - Paratek Pharmaceuticals, Inc.d853473dex1016.htm
EX-10.23 - EX-10.23 - Paratek Pharmaceuticals, Inc.d853473dex1023.htm
EX-10.17 - EX-10.17 - Paratek Pharmaceuticals, Inc.d853473dex1017.htm
EX-10.18 - EX-10.18 - Paratek Pharmaceuticals, Inc.d853473dex1018.htm
EXCEL - IDEA: XBRL DOCUMENT - Paratek Pharmaceuticals, Inc.Financial_Report.xls
EX-10.24 - EX-10.24 - Paratek Pharmaceuticals, Inc.d853473dex1024.htm

Exhibit 16.2

April 2, 2015

Securities and Exchange Commission

100 F Street, N.E.

Washington, DC 20549

Commissioners:

We have read the statements made by Paratek Pharmaceuticals, Inc. (copy attached), which we understand will be filed with the Securities and Exchange Commission, pursuant to Item 9 of Form 10-K, as part of the Form 10-K of Paratek Pharmaceuticals, Inc. dated April 2, 2015. We agree with the statements concerning our Firm in such Form 10-K.

Very truly yours,

/s/ PricewaterhouseCoopers L.L.P.

Paratek Pharmaceuticals, Inc. Reports